Cleared Traditional

K842731 - FORMALIN-ACETO-ALCOHOL FIXATIVE (FDA 510(k) Clearance)

Class I Pathology device.

K842731 · E K Ind., Inc. · Pathology device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Sep 1984
Decision
60d
Days
Class 1
Risk

K842731 is an FDA 510(k) clearance for the FORMALIN-ACETO-ALCOHOL FIXATIVE. Classified as Solution, Formalin-alcohol-acetic Acid (product code IGF), Class I - General Controls.

Submitted by E K Ind., Inc. (Mchenry, US). The FDA issued a Cleared decision on September 11, 1984 after a review of 60 days - a notably fast clearance cycle.

This device falls under the Pathology FDA review panel, regulated under 21 CFR 864.4010 - the FDA pathology device framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Fast-track predicate clearance. Standard predicate reliance. The short review cycle indicates strong predicate alignment - the FDA found sufficient equivalence without extended technical review.

View all E K Ind., Inc. devices

Submission Details

510(k) Number K842731 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received July 13, 1984
Decision Date September 11, 1984
Days to Decision 60 days
Submission Type Traditional
Review Panel Pathology (PA)
Summary -
Third-party Review No - reviewed directly by FDA
Regulatory Context
Review time vs. panel average
17d faster than avg
Panel avg: 77d · This submission: 60d
Pathway characteristics
Predicate-based equivalence.

Device Classification

Product Code IGF Solution, Formalin-alcohol-acetic Acid
Device Class Class 1 - General Controls
CFR Regulation 21 CFR 864.4010
What this classification means

Class I devices are subject to general controls only and most are exempt from 510(k) premarket notification. They represent the lowest regulatory burden in the FDA device framework.